GHK-Cu vs BPC-157

Overview

GHK-Cu and BPC-157 are sometimes considered together because both appear in tissue-remodelling and wound-model literature, but they sit at opposite ends of that field. GHK-Cu is a small, naturally occurring copper tripeptide most heavily studied in skin and connective-tissue research, where the focus is on collagen synthesis, extracellular-matrix remodelling, and broad changes in gene expression. BPC-157 is a synthetic pentadecapeptide derived from a protein found in gastric juice, studied far more often in gastrointestinal and animal tissue models, in relation to pathways such as the nitric oxide system and growth-factor signalling.

The simplest way to frame the comparison is dermal and cell-culture models on one side and gastrointestinal and animal tissue models on the other. They are distinct molecules with distinct mechanisms, and the appropriate choice depends entirely on the research model in question.

At a Glance

GHK-Cu in Brief

GHK-Cu is the tripeptide Glycyl-L-Histidyl-L-Lysine complexed with a copper(II) ion. It was first identified in human plasma by Dr. Loren Pickart in 1973 and is present in young adults at roughly 200 ng/mL, declining with age. Research has centred on dermal and connective-tissue endpoints: collagen and glycosaminoglycan synthesis in fibroblast cultures, metalloproteinase regulation, and gene-expression changes reported across thousands of human genes in cell-line data (Pickart et al., 2015). This profile places GHK-Cu firmly in dermal and cell-culture research models.

For the full mechanism, molecular profile and study list, see the GHK-Cu research guide.

BPC-157 in Brief

BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide based on a partial sequence of a protein isolated from human gastric juice. Published animal and cell studies have examined it largely in relation to the nitric oxide system, growth-factor expression (VEGF, EGF and FGF), and the FAK-paxillin signalling pathway involved in cell adhesion and migration (Sikiric et al., 2018). A distinguishing feature is its stability in gastric juice, which has made it a focus of gastrointestinal and animal tissue-model research rather than dermal models.

For the full mechanism, molecular profile and study list, see the BPC-157 research guide.

Key Mechanistic Differences

The two peptides are studied through largely separate primary pathways and in different model systems:

• Pathway focus: GHK-Cu research centres on collagen and extracellular-matrix synthesis and on genome-wide changes in gene expression, whereas BPC-157 research centres on the nitric oxide system and growth-factor signalling.
• Research context: GHK-Cu is studied predominantly in dermal, skin and connective-tissue models; BPC-157 appears more often in gastrointestinal, tendon and other animal tissue models.
• Size and structure: GHK-Cu is a compact three-residue peptide bound to a copper ion; BPC-157 is a larger 15-amino-acid sequence with no metal cofactor.
• Origin: GHK-Cu occurs naturally in human plasma, saliva and urine, while BPC-157 is a synthetic peptide that does not occur naturally in its isolated 15-amino-acid form.
• Distinguishing property: GHK-Cu is noted for the breadth of its reported gene-expression changes (around 4,000 human genes in cell-line data), while BPC-157 is noted for its stability in gastric juice.

Why the Two Are Sometimes Compared

Although their primary mechanisms differ, both peptides are associated with tissue-remodelling and wound-model research, which is why they occasionally appear together in combined-pathway studies and in pre-combined research blends. The two are studied in different pathways: GHK-Cu in dermal collagen and matrix models, BPC-157 in gastrointestinal and angiogenesis models.

Enhanced Research Compounds supplies both peptides individually, as well as in pre-combined research blends. The GLOW blend pairs GHK-Cu with peptides such as BPC-157 and TB-500 for multi-compound laboratory research. Researchers comparing tissue-model peptides specifically may also find the BPC-157 vs TB-500 comparison useful as a companion reference.

Molecular Profiles

Key Published Research

Purity and Sourcing

For research use, both peptides should be verified at ≥98% purity by HPLC, with a certificate of analysis confirming purity, identity and the absence of contaminants. Storage is broadly similar: keep lyophilised material at -20°C, reconstitute with sterile or bacteriostatic water for laboratory use, refrigerate at 2-8°C, and avoid repeated freeze-thaw cycles. Note that GHK-Cu solutions may appear blue due to the copper ion, which is a normal property of the complex.

Frequently Asked Questions